Cargando...

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma

As one of the most common malignant tumors worldwide, hepatocellular carcinoma (HCC) is known for its poor prognosis due to diagnosis only in advanced stages. Nearly 50% of the patients with the first diagnosis of HCC die within a year. Currently, the advancements in the integration of omics informa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Biol Sci
Main Authors: Wu, Xiaolin, Li, Jiahui, Gassa, Asmae, Buchner, Denise, Alakus, Hakan, Dong, Qiongzhu, Ren, Ning, Liu, Ming, Odenthal, Margarete, Stippel, Dirk, Bruns, Christiane, Zhao, Yue, Wahba, Roger
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2020
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7097921/
https://ncbi.nlm.nih.gov/pubmed/32226301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.44024
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!